Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 811-816

  Van Der Does, Anne M ^a   Bogaards, Sylvia J P ^b   Ravensbergen, Bep ^a   Beekhuizen, Henry ^a   Van Dissel, Jaap T ^a   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AM Pharma   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PEPTIDE HLF1 11; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL DIFFERENTIATION; CELL STIMULATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE DEFICIENCY; MACROPHAGE; MICROORGANISM DETECTION; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MONOCYTES; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 75749088351     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00652-09     Document Type: Article

References (20)

1. Bowdish, D. M., M. S. Loffredo, S. Mukhopadhyay, A. Mantovani, and S. Gordon. 2007. Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes. Infect. 9:1680-1687.
2. Chan, D. I., E. J. Prenner, and H. J. Vogel. 2006. Tryptophan- and argininerich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 1758:1184-1202.
3. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771-5777.
4. Dijkshoorn, L., C. P. Brouwer, S. J. Bogaards, A. Nemec, P. J. van den Broek, and P. H. Nibbering. 2004. The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48:4919-4921.
5. Ferwerda, G., F. Meyer-Wentrup, B. J. Kullberg, M. G. Netea, and G. J. Adema. 2008. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol. 10:2058-2066.
6. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and auto-immunity. Nat. Rev. Immunol. 8:533-544.
7. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
8. Hum, D. A. 2006. The mononuclear phagocyte system. Curr. Opin. Immunol. 18:49-53.
9. Lupetti, A., C. P. Brouwer, S. J. Bogaards, M. M. Welling, E. de Heer, M. Campa, J. T. van Dissel, R. H. Friesen, and P. H. Nibbering. 2007. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J. Infect. Dis. 196:1416-1424.
10. Lupetti, A., A. Paulusma-Annema, M. M. Welling, H. Dogterom-Ballering, C. P. Brouwer, S. Senesi, J. T. van Dissel, and P. H. Nibbering. 2003. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob. Agents Chemother. 47:262-267.
11. Lupetti, A., A. Paulusma-Annema, M. M. Welling, S. Senesi, J. T. Van Dissel, and P. H. Nibbering. 2000. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44:3257-3263.
12. Nibbering, P. H., E. Ravensbergen, M. M. Welling, L. A. van Berkel, P. H. van Berkel, E. K. Pauwels, and J. H. Nuijens. 2001. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69:1469-1476.
13. Nibbering, P. H., M. M. Welling, A. Paulusma-Annema, C. P. Brouwer, A. Lupetti, and E. K. Pauwels. 2004. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J. Nucl. Med. 45:321-326.
14. Scott, M. G., E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, J. J. Yu, Y. Li, O. Donini, M. M. Guarna, B. B. Finlay, J. R. North, and R. E. Hancock. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25:465-472.
15. van der Velden, W. J., T. M. van Iersel, N. M. Blijlevens, and J. P. Donnelly. 2009. Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). BMC Med. 7:44.
16. Verreck, F. A., T. de Boer, D. M. Langenberg, L. van der Zanden, and T. H. Ottenhoff. 2006. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukoc. Biol. 79:285-293.
17. Willment, J. A., and G. D. Brown. 2008. C-type lectin receptors in antifungal immunity. Trends Microbiol. 16:27-32.
18. Xu, W., A. Roos, N. Schlagwein, A. M. Woltman, M. R. Daha, and C. van Kooten. 2006. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107:4930-4937.
19. Zaiou, M. 2007. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85:317-329.
20. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.